16 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
HBIO Harvard Bioscience, Inc. $5.35 $195.7M N/A
Article Searches
Harvard Bioscience, Inc. (HBIO) CEO Jeffrey Duchemin on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4259879-harvard-bioscience-inc-hbio-ceo-jeffrey-duchemin-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 03, 2019 - Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2019 Earnings Conference Call May 2, 2019 04:30 PM ET Company Participants Corey Manchester – Vice President and Corporate Controller Jeffrey Duchemin – Presi
Harvard Bioscience, Inc. (HBIO) CEO Jeffrey Duchemin on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4245487-harvard-bioscience-inc-hbio-ceo-jeffrey-duchemin-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare Feb 28, 2019 - Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2018 Earnings Conference Call February 28, 2019, 16:30 ET Company Participants Corey Manchester - VP & Corporate Controller Jeffrey Duchemin - CEO, Presid
Harvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4214689-harvard-biosciences-hbio-ceo-jeffrey-duchemin-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Oct 25, 2018 - Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2018 Earnings Conference Call October 25, 2018 4:30 PM ET Executives Jeffrey Duchemin – President and Chief Executive Officer Corey Manchester – Vice Presiden
Harvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q1 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4168902-harvard-biosciences-hbio-ceo-jeffrey-duchemin-q1-2018-results-earnings-call-transcript?source=feed_sector_healthcare May 02, 2018 - Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2018 Earnings Conference Call May 2, 2018 4:30 P.M. ET Executives Corey Manchester - Director, Finance and Investor Relations Jeffrey Duchemin - President and
Zacks.com featured highlights include: TheStreet, Joint, Harvard Bioscience and CPI http://www.zacks.com/stock/news/300649/zackscom-featured-highlights-include-thestreet-joint-harvard-bioscience-and-cpi?cid=CS-ZC-FT-300649 Apr 25, 2018 - Zacks.com featured highlights include: TheStreet, Joint, Harvard Bioscience and CPI
4 Breakout Stocks Offering Phenomenal Returns http://www.zacks.com/stock/news/300323/4-breakout-stocks-offering-phenomenal-returns?cid=CS-ZC-FT-300323 Apr 24, 2018 - If properly implemented, such a strategy has the ability to deliver impressive returns.
Can The Uptrend Continue for Harvard Bioscience (HBIO)? http://www.zacks.com/stock/news/299020/can-the-uptrend-continue-for-harvard-bioscience-hbio?cid=CS-ZC--299020 Apr 12, 2018 - Investors certainly have to be happy with Harvard Bioscience, Inc. (HBIO) and its short term performance
4 Top-Ranked Tech Stocks Under $20 With Room to Run http://www.zacks.com/stock/news/296558/4-top-ranked-tech-stocks-under-%2420-with-room-to-run?cid=CS-ZC-FT-296558 Mar 22, 2018 - Technology stocks like Harvard Bioscience (HBIO) and TechTarget, Inc. (TTGT), among others, have great growth potential.
Harvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q4 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4152595-harvard-biosciences-hbio-ceo-jeffrey-duchemin-q4-2017-results-earnings-call-transcript?source=feed_sector_healthcare Mar 01, 2018 - Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2017 Earnings Conference Call March 01, 2018, 16:30 ET Executives Corey Manchester - Director, Finance & IR Jeffrey Duchemin - President, CEO & Direct
Harvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q3 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4139385-harvard-biosciences-hbio-ceo-jeffrey-duchemin-q3-2017-results-earnings-call-transcript?source=feed_sector_healthcare Jan 23, 2018 - Harvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2017 Earnings Conference Call January 23, 2018 07:30 AM ET Executives Corey Manchester - Director, Finance and IR Jeffrey Duchemin - President and CEO Robert

Pages: 12

Page 1